CVS Health

Registered Principal Details

Business Or Interest:
Retail Pharmacy, PBM, Specialty, Retail Clinics

Lobbying Interests:
Healthcare

CEO Name:
Larry Merlo

Contact
SP
Shannon Picozzi
1 CVS Drive, Mail Code 1171
Woonsocket, RI 02895
(401) 770-2406
Shannon.Picozzi@CVSHealth.com
http://www.cvshealth.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 1
Assembly Bill 1
Relating to: coverage of individuals with preexisting conditions.

Bill Text and History

None
Notification Date
2/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 24
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

None
Notification Date
2/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 114
Assembly Bill 114
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

None
Notification Date
3/27/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

2019 Wisconsin Act 12

None
Notification Date
2/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 100
Senate Bill 100
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

Against
Notification Date
3/27/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Matters pertaining to Pharmacy Benefit Managers
Development, drafting or introduction of a proposal relating to
Matters pertaining to Pharmacy Benefit Managers

Action Intended To Affect
Legislative matter

Notification Date
1/17/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters pertaining to Maximum Allowable Costs (MAC) for pharmaceuticals
Development, drafting or introduction of a proposal relating to
Matters pertaining to Maximum Allowable Costs (MAC) for pharmaceuticals

Action Intended To Affect
Legislative matter

Notification Date
1/17/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
Total Lobbying Expenditures 2019
January - June
$18,000.00
2019
July - December
$18,000.00
2020
January - June
$18,000.00
2020
July - December
$18,000.00
Total $72,000.00
Total Hours Communicating 2019
January - June
18.00
2019
July - December
16.00
2020
January - June
18.00
2020
July - December
0.00
Total 52.00
Total Hours Other 2019
January - June
72.00
2019
July - December
96.00
2020
January - June
60.00
2020
July - December
96.00
Total 324.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
15%
2019
July - December
2020
January - June
2020
July - December
Total 4%
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
15%
2019
July - December
2020
January - June
2020
July - December
Total 4%
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
35%
2019
July - December
50%
2020
January - June
50%
2020
July - December
Total 34%
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
35%
2019
July - December
50%
2020
January - June
50%
2020
July - December
Total 34%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
2020
July - December
100%
Total 26%

Filed Statements of Lobbying Activity and Expenditures